Trials / Not Yet Recruiting
Not Yet RecruitingNCT07047508
Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction
A Non-interventional Study of the Effectiveness and Safety Outcomes in Patients With Heart Failure and Preserved Ejection Fraction (HFpEF) Initiating Jardiance in China: A Sub-study of the Post-marketing Study of Jardiance Among Patients With Heart Failure in China
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to describe the effectiveness and safety outcomes among Chinese hospitalized heart failure with preserved ejection fraction (HFpEF) patients initiating Jardiance® in the real-world setting.
Conditions
Timeline
- Start date
- 2028-01-31
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2025-07-02
- Last updated
- 2026-02-13
Source: ClinicalTrials.gov record NCT07047508. Inclusion in this directory is not an endorsement.